Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.65 (-0.30) | AIM:£2.29 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor